| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 132,863 | 135,180 | 133,459 | 132,686 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 135,180 | 133,459 | 132,686 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 33,065 | 126,853 | 118,004 | 124,333 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 86,160 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,235 | 8,327 | 15,455 | 8,353 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 13,638 | 8,327 | 15,455 | 8,353 | | Interest Expense | 2,421 | 2,476 | 2,506 | 2,674 | | Income Before Tax | 11,217 | 5,851 | 12,949 | 5,679 | | Income Tax Expense | 3,968 | 2,084 | 4,646 | 1,945 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,249 | 3,767 | 8,303 | 3,734 | | | Non-recurring Events | | Discontinued Operations | (40) | (1,165) | (86) | (7,840) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,209 | 2,602 | 8,217 | (4,106) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,209 | $2,602 | $8,217 | ($4,106) |
|
0.25% Nasdaq 
0.02%
Income Statement
